On Invalid Date, Volitionrx (NYSEMKT: VNRX) reported Q1 2023 earnings per share (EPS) of -$0.15, up 7.14% year over year. Total Volitionrx earnings for the quarter were -$8.78 million. In the same quarter last year, Volitionrx's earnings per share (EPS) was -$0.14.
As of Q2 2023, Volitionrx's earnings has grown year over year. Volitionrx's earnings in the past year totalled -$31.41 million.
What was VNRX's revenue last quarter?
On Invalid Date, Volitionrx (NYSEMKT: VNRX) reported Q1 2023 revenue of $149.81 thousand up 31.17% year over year. In the same quarter last year, Volitionrx's revenue was $114.21 thousand.
What was VNRX's revenue growth in the past year?
As of Q2 2023, Volitionrx's revenue has grown 91.36% year over year. This is 85.44 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 5.92%. Volitionrx's revenue in the past year totalled $341.99 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.